FDA NDC Directory · JSON-LD · Markdown

cisatracurium besylate

NDC 72785-0008 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA212171
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsCISATRACURIUM BESYLATE (2 mg/mL)
Marketing started20200212
Package count1

External sources

Source: openFDA. Public-domain (CC0).